Riskpilot← Back to searchSign inGet full accessWELLAND NORGE AS
ASActiveOrg 819115052Hulderveien 19, 7506 StjørdalWholesale of pharmaceutical and medical goods · NACE 4646Est. 20172 employees
Revenue 2024
NOK 14,7M
+10% vs 2023
EBITDA margin
11.4%
-12% vs 2023
Equity ratio
13.8%
Financial strength
Net profit 2024
NOK 1,3M
-6% vs 2023
| Revenue | NOK 14,7M | +10% |
| EBITDA | NOK 1,7M | -12% |
| Net profit | NOK 1,3M | -6% |
| Total assets | NOK 6,2M | -15% |
| Equity | NOK 857K | -21% |
| Employees | 2 | — |
Legal name
WELLAND NORGE AS
Org number
819115052
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10. juni 2017
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Brynhild forbord
Company purpose
Engroshandel med sykepleie- og apotekvarer.
Address
Hulderveien 19, 7506 Stjørdal
Email
post@welland.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 787 | 9 025 | 11 658 | 13 443 | 14 740 |
| Staff expenses | −1 812 | −2 051 | −2 190 | −2 485 | −1 913 |
| EBITDA | 1 072 | 1 425 | 1 390 | 1 908 | 1 686 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 072 | 1 425 | 1 390 | 1 908 | 1 686 |
| Net financials | −21 | −35 | −44 | −93 | 29 |
| Profit before tax | 1 051 | 1 390 | 1 345 | 1 816 | 1 716 |
| Tax | 231 | 306 | 296 | 399 | 377 |
| Net profit | 820 | 1 084 | 1 049 | 1 416 | 1 338 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 293 | 4 015 | 5 871 | 7 315 | 6 192 |
| Equity | 479 | 1 063 | 675 | 1 091 | 857 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 814 | 2 952 | 5 196 | 6 224 | 5 335 |
| Total debt | 1 814 | 2 952 | 5 196 | 6 224 | 5 335 |
EBITDA margin
11.4%
This company
15.8%
Market median
-28% vs market
20202024
Equity ratio
13.8%
This company
38.2%
Market median
-64% vs market
20202024
Return on equity
156.2%
This company
18.4%
Market median
+749% vs market
20202024
Net profit margin
9.1%
This company
8.1%
Market median
+12% vs market
20202024
Asset turnover
2.38×
This company
1.12×
Market median
+112% vs market
20202024
Debt / equity
6.23×
This company
0.62×
Market median
-905% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
BF Chief Executive Officer | Chief Executive Officer | 2017 |
RF Deputy Member | Deputy Member | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Brynhild Forbord Holding As
WELLAND NORGE AS Board members of WELLAND NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Brynhild Forbord | Chief Executive Officer | 0 companies |
| Rune Forbord | Deputy Member | 0 companies |
| Daniel Flaamo | Chairman | 0 companies |